Back in Business: Seattle's ACT Announces Upcoming 2003 Season | Playbill

Related Articles
News Back in Business: Seattle's ACT Announces Upcoming 2003 Season Seattle's ACT Theatre — which was in danger of closing — is back up and running, ready for their next season. The Washington stage has announced a five-play season including works by Alan Ayckbourn, Edward Albee, Pamela Gien and Eugene O'Neill as well as its traditional production of A Christmas Carol.

Under ACT’s new artistic director, Kurt Beattie, the season will kick off with Absurd Person Singular by Alan Ayckbourn, July 11-Aug. 3. Featuring a cast that includes Julie Briskman, Liz McCarthy, Marianne Owen, Larry Paulsen, Michael Winters and R. Hamilton Wright, the comedy will be directed by Jeff Steitzer.

The west coast premiere of Albee's Tony Award-winning play The Goat, or Who Is Sylvia? will make its way to the ACT stage under the direction of Warner Shook. The show which caused much controversy on Broadway expects to shock Seattle audiences, July 25-Aug. 17.

O’Neill's A Moon for the Misbegotten will take the stage Sept. 5-28. Artistic director Beattie will direct the Tyrone family drama featuring John Proccacino and Jeanne Paulsen.

A final play will be announced shortly to fill the Oct. 3-26 slot. Gien's The Syringa Tree will follow Oct. 31-Nov. 23. The solo show which enjoyed a run Off-Broadway began ACT’s Bullitt stage in 1999. Larry Moss will direct the South Africa-based work.

ACT holiday tradition calls for a production of A Christmas Carol, Nov. 28-Dec. 27. The classic Charles Dickens tale as adapted by Gregory Falls is in its 28th year of production. Subscriptions to ACT Theatre shows are currently available through at the ACT Ticket Office, on the corner of 7th Avenue and Union Street, by calling (206) 292-7676 or online at www.acttheatre.org. Individual tickets will go on sale June 15.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!